- Home
- APLS vs NBTB Comparison
APLS vs NBTB Comparison
Compare APLS & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLS | NBTB |
|---|---|---|
| Founded | 2009 | 1856 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | APLS | NBTB |
|---|---|---|
| Price | $20.64 | $42.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 3 |
| Target Price | $31.79 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 1.9M | 194.4K |
| Earning Date | 04-02-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | ★ 112.50 | 12.12 |
| EPS | 0.20 | ★ 3.33 |
| Revenue | ★ $1,003,782,000.00 | $182,952,000.00 |
| Revenue This Year | N/A | $14.37 |
| Revenue Next Year | $17.57 | $5.15 |
| P/E Ratio | $103.98 | ★ $18.87 |
| Revenue Growth | ★ 28.46 | 10.40 |
| 52 Week Low | $16.10 | $37.31 |
| 52 Week High | $30.48 | $46.92 |
Technical Indicators
Market Signals| Indicator | APLS | NBTB |
|---|---|---|
| Relative Strength Index (RSI) | 38.18 | 39.90 |
| Support Level | $18.95 | $41.90 |
| Resistance Level | $24.37 | $42.97 |
| Average True Range (ATR) | 0.97 | 1.36 |
| MACD | -0.14 | -0.39 |
| Stochastic Oscillator | 20.13 | 27.69 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About NBTB NBT Bancorp Inc.
NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.